TrialAntimicrobial agents and chemotherapy2011

Randomized, double-blind, phase II, multicenter study evaluating the safety/tolerability and efficacy of JNJ-Q2, a novel fluoroquinolone, compared with linezolid for treatment of acute bacterial skin and skin structure infection.

Paul Covington et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.